However, the percentage of IL-10+ B cells in LN patients is negatively correlated with the daily dose of prednisolone (117) which indicates that the currently available immunosuppressive agents can affect both the effector and regulatory aspects of B cells. This evidence concerns the gene IL10 and lobular neoplasia.